Accuray Incorporated

ARAY | Healthcare | NASDAQ
$0.33
+0.02 (+5.18%)

Key Metrics

Market Cap
$39.14M
P/E Ratio
-0.89
EPS
$-0.37
Beta
N/A
Dividend Yield
N/A
ROE
-77.48%
Current Ratio
1.42

Company Information

Industry
Medical Devices

About Accuray Incorporated

Accuray Incorporated specializes in the design development production and sale of advanced radiosurgery and radiation therapy equipment aimed at treating tumors Their market footprint spans across North and South America Australia New Zealand Europe the Middle East India Africa Japan China and the broader Asia Pacific region Among their core offerings is the CyberKnife System a sophisticated robotic platform for stereotactic radiosurgery and stereotactic body radiation therapy This system is employed to target both primary and metastatic tumors located outside the brain specifically addressing areas such as the spine breast kidney liver lung pancreas and prostate They also provide the TomoTherapy System which encompasses the Radixact System designed to deliver highly precise radiation treatments up to 50 patients daily through integrated planning delivery and data management capabilities Complementing these are the iDMS data management system and the Accuray precision treatment planning system both offering comprehensive solutions for treatment planning and data handling In addition to their technology Accuray offers crucial postsale services including customer support system installation training and various other professional services The company primarily engages directly with its clientele which includes hospitals and specialized treatment centers through its dedicated sales force In the United States they also leverage sales agents and group purchasing organizations while internationally their reach extends through distributors and sales agents Established in 1990 Accuray Incorporated maintains its corporate headquarters in Madison Wisconsin

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2026-05-06 $-0.09 $-0.05 80.0%
2026-02-04 $-0.11 $-0.11 2.2%
2025-11-05 $-0.18 $-0.01 1,700.0%
2025-08-13 $0.01 $0.03 -65.6%

Financial Ratios (TTM)

Gross Margin
26.81%
Operating Margin
-3.53%
Net Margin
-10.76%
ROA
-10.31%
Price to Book
0.98
Price to Sales
0.09